Ping Bu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ping Bu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Brent A. Bell
Department of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
1 shared publication- Chandana Sooranahalli
Department of Ophthalmology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
1 shared publication - Charles Bouchard
Department of Ophthalmology, Loyola University Medical Center, Maywood, IL 60153, USA
1 shared publication Charles Kaul
Department of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
1 shared publicationCraig Beight
Department of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
1 shared publicationGwen Sturgill-Short
Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 7, 1001430
The potential role of high mobility group box 1 (HMGB-1) protein in the pathogenesis of keratoconus: a pilot immunofluorescence study
Aim: This preliminary study aims to evaluate the expression of high mobility group box 1 (HMGB-1) in keratoconic corneas, normal corneas, and corneas from donors with Fuchs’ corneal dystrophy using immunohistochemistry. Methods: Under a Loyola University Institutional Review Board (IRB) approved protocol (LU#219768), archived paraffin-embedded corneal tissues were obtained from the Loyola University Medical Center Department of Pathology. The study included three keratoconic corneas, three normal donor corneas, and three Fuchs’ dystrophy corneas. Tissue sections were deparaffinized in 100% xylene, rehydrated through a graded ethanol series, and subjected to antigen retrieval. Sections were stained with an HMGB-1 primary antibody, followed by a fluorescently conjugated anti-rabbit IgG secondary antibody and 4',6-diamidino-2-phenylindole (DAPI) nuclear counterstain. Immunofluorescence imaging and deconvolution analysis were performed using a Nikon Eclipse Ti2 microscope equipped with a digital camera. Two prespecified comparisons, keratoconus versus normal and Fuchs’ dystrophy versus normal, were evaluated using Welch’s independent-samples t tests with Holm adjustment for multiple testing. Statistical analyses were performed using IBM SPSS Statistics. Results: HMGB-1 expression was increased in corneal tissues from patients with keratoconus and Fuchs’ corneal dystrophy compared with normal controls. The increased levels of HMGB-1 suggest enhanced activation of pro-inflammatory and tissue-remodeling pathways. Increased HMGB-1 expression in keratoconus may be associated with cellular stress, inflammation, and extracellular matrix remodeling. Conclusions: These preliminary findings suggest that HMGB-1 expression may be increased in keratoconus; however, due to the small sample size of n = 3 per group, larger studies are needed to confirm this association and clarify its potential role in disease pathogenesis. These findings suggest that HMGB-1 may be associated with corneal cellular stress and inflammatory signaling present in keratoconic corneas and warrant further investigation and validation.
- 13 October 2026
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 7, 1001430
Open AccessThe potential role of high mobility group box 1 (HMGB-1) protein in the pathogenesis of keratoconus: a pilot immunofluorescence study
Aim: This preliminary study aims to evaluate the expression of high mobility group box 1 (HMGB-1) in keratoconic corneas, normal corneas, and corneas from donors with Fuchs’ corneal dystrophy using immunohistochemistry. Methods: Under a Loyola University Institutional Review Board (IRB) approved protocol (LU#219768), archived paraffin-embedded corneal tissues were obtained from the Loyola University Medical Center Department of Pathology. The study included three keratoconic corneas, three normal donor corneas, and three Fuchs’ dystrophy corneas. Tissue sections were deparaffinized in 100% xylene, rehydrated through a graded ethanol series, and subjected to antigen retrieval. Sections were stained with an HMGB-1 primary antibody, followed by a fluorescently conjugated anti-rabbit IgG secondary antibody and 4',6-diamidino-2-phenylindole (DAPI) nuclear counterstain. Immunofluorescence imaging and deconvolution analysis were performed using a Nikon Eclipse Ti2 microscope equipped with a digital camera. Two prespecified comparisons, keratoconus versus normal and Fuchs’ dystrophy versus normal, were evaluated using Welch’s independent-samples t tests with Holm adjustment for multiple testing. Statistical analyses were performed using IBM SPSS Statistics. Results: HMGB-1 expression was increased in corneal tissues from patients with keratoconus and Fuchs’ corneal dystrophy compared with normal controls. The increased levels of HMGB-1 suggest enhanced activation of pro-inflammatory and tissue-remodeling pathways. Increased HMGB-1 expression in keratoconus may be associated with cellular stress, inflammation, and extracellular matrix remodeling. Conclusions: These preliminary findings suggest that HMGB-1 expression may be increased in keratoconus; however, due to the small sample size of n = 3 per group, larger studies are needed to confirm this association and clarify its potential role in disease pathogenesis. These findings suggest that HMGB-1 may be associated with corneal cellular stress and inflammatory signaling present in keratoconic corneas and warrant further investigation and validation.
- 3 July 2015
- Published by Elsevier in Experimental Eye Research
- Vol. 138, 126-133
Deficiency of CC chemokine ligand 2 and decay-accelerating factor causes retinal degeneration in mice
- 3 July 2015
- Published by Elsevier in Experimental Eye Research
- Vol. 138, 126-133
Deficiency of CC chemokine ligand 2 and decay-accelerating factor causes retinal degeneration in mice